Sight Sciences, Inc. Financials
Financial Health Signals
Based on FY2024 annual data. Scores normalized against common benchmarks. How we calculate these scores
Sight Sciences, Inc. has an operating margin of -63.3%, meaning the company retains $-63 of operating profit per $100 of revenue. This below-average margin results in a low score of 0/100, suggesting thin profitability after operating expenses. This is up from -70.7% the prior year.
Sight Sciences, Inc.'s revenue declined 1.5% year-over-year, from $81.1M to $79.9M. This contraction results in a growth score of 24/100.
Sight Sciences, Inc. carries a low D/E ratio of 0.45, meaning only $0.45 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 94/100, indicating a strong balance sheet with room for future borrowing.
With a current ratio of 9.04, Sight Sciences, Inc. holds $9.04 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 100/100.
While Sight Sciences, Inc. generated -$22.4M in operating cash flow, capex of $385K consumed most of it, leaving -$22.7M in free cash flow. This results in a low score of 0/100, reflecting heavy capital investment rather than weak cash generation.
Sight Sciences, Inc. passes 3 of 9 financial strength tests. 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.
For every $1 of reported earnings, Sight Sciences, Inc. generates $0.43 in operating cash flow (-$22.4M OCF vs -$51.5M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
Sight Sciences, Inc. earns $-10.8 in operating income for every $1 of interest expense (-$50.5M vs $4.7M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
This page shows Sight Sciences, Inc. (SGHT) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 5 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Key Financial Metrics
Sight Sciences, Inc. generated $79.9M in revenue in fiscal year 2024. This represents a decrease of 1.5% from the prior year.
Sight Sciences, Inc.'s EBITDA was -$49.8M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 12.1% from the prior year.
Sight Sciences, Inc. generated -$22.7M in free cash flow in fiscal year 2024, representing cash available after capex. This represents an increase of 52.6% from the prior year.
Sight Sciences, Inc. reported -$51.5M in net income in fiscal year 2024. This represents an increase of 7.3% from the prior year.
Sight Sciences, Inc. earned $-1.03 per diluted share (EPS) in fiscal year 2024. This represents an increase of 9.6% from the prior year.
Sight Sciences, Inc. held $120.4M in cash against $39.4M in long-term debt as of fiscal year 2024.
Sight Sciences, Inc. had 51M shares outstanding in fiscal year 2024. This represents an increase of 3.7% from the prior year.
Sight Sciences, Inc.'s gross margin was 85.5% in fiscal year 2024, indicating the percentage of revenue retained after direct costs. This is up 0.2 percentage points from the prior year.
Sight Sciences, Inc.'s operating margin was -63.3% in fiscal year 2024, reflecting core business profitability. This is up 7.4 percentage points from the prior year.
Sight Sciences, Inc.'s net profit margin was -64.5% in fiscal year 2024, showing the share of revenue converted to profit. This is up 4.0 percentage points from the prior year.
Sight Sciences, Inc. invested $18.0M in research and development in fiscal year 2024. This represents an increase of 2.5% from the prior year.
Sight Sciences, Inc. invested $385K in capex in fiscal year 2024, funding long-term assets and infrastructure. This represents a decrease of 51.3% from the prior year.
SGHT Income Statement
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $19.9M+1.7% | $19.6M+11.7% | $17.5M-8.2% | $19.1M-10.7% | $21.4M+10.9% | $19.3M+2.7% | $18.8M-6.3% | $20.0M |
| Cost of Revenue | $2.7M-9.0% | $3.0M+23.3% | $2.4M-3.9% | $2.5M-16.9% | $3.0M+8.3% | $2.8M+0.6% | $2.8M+3.7% | $2.7M |
| Gross Profit | $17.2M+3.7% | $16.6M+9.9% | $15.1M-8.9% | $16.6M-9.7% | $18.3M+11.4% | $16.5M+3.1% | $16.0M-7.8% | $17.3M |
| R&D Expenses | $3.4M-23.6% | $4.4M-1.0% | $4.4M+3.2% | $4.3M-0.5% | $4.3M-6.9% | $4.6M+35.3% | $3.4M-19.2% | $4.2M |
| SG&A Expenses | $21.8M-8.9% | $23.9M-2.7% | $24.5M+1.3% | $24.2M-9.3% | $26.7M+0.5% | $26.6M+12.3% | $23.7M-10.7% | $26.5M |
| Operating Income | -$7.9M+32.2% | -$11.7M+15.8% | -$13.9M-16.2% | -$11.9M+5.7% | -$12.7M+14.1% | -$14.7M-32.5% | -$11.1M+17.2% | -$13.4M |
| Interest Expense | $1.3M+1.7% | $1.3M+1.7% | $1.3M+8.7% | $1.2M+1.5% | $1.1M-4.9% | $1.2M-10.9% | $1.4M-5.7% | $1.4M |
| Income Tax | -$79K-297.5% | $40K-2.4% | $41K+7.9% | $38K+153.3% | $15K-11.8% | $17K+70.0% | $10K-87.2% | $78K |
| Net Income | -$8.2M+31.6% | -$11.9M+15.6% | -$14.2M-19.5% | -$11.8M+3.9% | -$12.3M+24.2% | -$16.3M-52.1% | -$10.7M+18.0% | -$13.0M |
| EPS (Diluted) | $-0.16+30.4% | $-0.23+17.9% | $-0.28-21.7% | $-0.23+8.0% | $-0.25+24.2% | $-0.33-50.0% | $-0.22+18.5% | $-0.27 |
SGHT Balance Sheet
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $116.3M-4.7% | $122.0M-5.9% | $129.7M-9.2% | $142.8M-4.6% | $149.7M-3.8% | $155.6M-6.7% | $166.7M-5.7% | $176.6M |
| Current Assets | $113.6M-4.9% | $119.4M-5.9% | $126.9M-9.2% | $139.8M-4.5% | $146.3M-3.8% | $152.1M-6.6% | $162.9M-6.2% | $173.6M |
| Cash & Equivalents | $92.4M-9.0% | $101.5M-6.7% | $108.8M-9.6% | $120.4M+1.8% | $118.2M-7.2% | $127.3M-7.9% | $138.1M-4.4% | $144.5M |
| Inventory | $8.0M+28.5% | $6.2M+7.0% | $5.8M-8.2% | $6.3M-6.7% | $6.8M-1.3% | $6.9M-12.5% | $7.8M-15.1% | $9.2M |
| Accounts Receivable | $9.7M+1.4% | $9.6M+2.0% | $9.4M-12.6% | $10.8M-45.9% | $19.9M+27.3% | $15.6M+9.5% | $14.3M-15.5% | $16.9M |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $52.0M0.0% | $52.0M-0.2% | $52.1M-5.9% | $55.3M+15.1% | $48.1M+3.7% | $46.4M-0.2% | $46.4M-6.3% | $49.6M |
| Current Liabilities | $11.8M-0.9% | $11.9M-1.5% | $12.1M-21.6% | $15.5M+16.4% | $13.3M+13.6% | $11.7M-4.6% | $12.3M-14.5% | $14.3M |
| Long-Term Debt | $40.1M+0.6% | $39.8M+0.6% | $39.6M+0.6% | $39.4M+16.5% | $33.8M+0.2% | $33.7M+6.3% | $31.7M-6.1% | $33.8M |
| Total Equity | $64.3M-8.2% | $70.0M-9.8% | $77.6M-11.3% | $87.5M-13.9% | $101.6M-6.9% | $109.2M-9.2% | $120.2M-5.4% | $127.1M |
| Retained Earnings | -$380.6M-2.2% | -$372.4M-3.3% | -$360.5M-4.1% | -$346.3M-7.1% | -$323.4M-4.0% | -$311.1M-5.5% | -$294.8M-3.8% | -$284.1M |
SGHT Cash Flow Statement
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$8.7M-15.6% | -$7.5M+35.0% | -$11.6M-235.5% | -$3.5M+63.5% | -$9.5M+3.2% | -$9.8M-50.9% | -$6.5M+34.0% | -$9.8M |
| Capital Expenditures | $170K-19.0% | $210K | $0-100.0% | $137K+71.3% | $80K-31.6% | $117K-55.7% | $264K-13.2% | $304K |
| Free Cash Flow | -$8.9M-14.7% | -$7.8M+33.2% | -$11.6M-222.7% | -$3.6M+62.3% | -$9.5M+3.6% | -$9.9M-46.8% | -$6.7M+33.4% | -$10.1M |
| Investing Cash Flow | -$170K+19.0% | -$210K | $0+100.0% | -$137K-71.3% | -$80K+31.6% | -$117K+55.7% | -$264K+13.2% | -$304K |
| Financing Cash Flow | $25K-94.8% | $485K+2931.3% | $16K-99.7% | $5.4M+1122.0% | $441K+146.8% | -$942K-350.5% | $376K+218.6% | $118K |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
SGHT Financial Ratios
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 86.4%+1.6pp | 84.8%-1.4pp | 86.2%-0.6pp | 86.8%+1.0pp | 85.8%+0.3pp | 85.5%+0.3pp | 85.2%-1.4pp | 86.6% |
| Operating Margin | -39.7%+19.9pp | -59.6%+19.5pp | -79.2%-16.6pp | -62.5%-3.3pp | -59.2%+17.2pp | -76.4%-17.2pp | -59.2%+7.8pp | -67.0% |
| Net Margin | -41.0%+20.0pp | -61.0%+19.8pp | -80.8%-18.7pp | -62.1%-4.4pp | -57.7%+26.7pp | -84.4%-27.4pp | -57.0%+8.1pp | -65.1% |
| Return on Equity | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets | -7.0%+2.8pp | -9.8%+1.1pp | -10.9%-2.6pp | -8.3%-0.1pp | -8.2%+2.2pp | -10.5%-4.0pp | -6.4%+1.0pp | -7.4% |
| Current Ratio | 9.60-0.4 | 10.01-0.5 | 10.47+1.4 | 9.04-2.0 | 11.01-2.0 | 13.01-0.3 | 13.29+1.2 | 12.11 |
| Debt-to-Equity | 0.62+0.1 | 0.57+0.1 | 0.51+0.1 | 0.45+0.1 | 0.33+0.0 | 0.31+0.0 | 0.260.0 | 0.27 |
| FCF Margin | -44.6%-5.0pp | -39.6%+26.6pp | -66.3%-47.4pp | -18.9%+25.8pp | -44.7%+6.7pp | -51.4%-15.4pp | -36.0%+14.6pp | -50.6% |
Similar Companies
Frequently Asked Questions
What is Sight Sciences, Inc.'s annual revenue?
Sight Sciences, Inc. (SGHT) reported $79.9M in total revenue for fiscal year 2024. This represents a -1.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Sight Sciences, Inc.'s revenue growing?
Sight Sciences, Inc. (SGHT) revenue declined by 1.5% year-over-year, from $81.1M to $79.9M in fiscal year 2024.
Is Sight Sciences, Inc. profitable?
No, Sight Sciences, Inc. (SGHT) reported a net income of -$51.5M in fiscal year 2024, with a net profit margin of -64.5%.
What is Sight Sciences, Inc.'s earnings per share (EPS)?
Sight Sciences, Inc. (SGHT) reported diluted earnings per share of $-1.03 for fiscal year 2024. This represents a 9.6% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.
What is Sight Sciences, Inc.'s EBITDA?
Sight Sciences, Inc. (SGHT) had EBITDA of -$49.8M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Sight Sciences, Inc. have?
As of fiscal year 2024, Sight Sciences, Inc. (SGHT) had $120.4M in cash and equivalents against $39.4M in long-term debt.
What is Sight Sciences, Inc.'s gross margin?
Sight Sciences, Inc. (SGHT) had a gross margin of 85.5% in fiscal year 2024, indicating the percentage of revenue retained after direct costs of goods sold.
What is Sight Sciences, Inc.'s operating margin?
Sight Sciences, Inc. (SGHT) had an operating margin of -63.3% in fiscal year 2024, reflecting the profitability of core business operations before interest and taxes.
What is Sight Sciences, Inc.'s net profit margin?
Sight Sciences, Inc. (SGHT) had a net profit margin of -64.5% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.
What is Sight Sciences, Inc.'s free cash flow?
Sight Sciences, Inc. (SGHT) generated -$22.7M in free cash flow during fiscal year 2024. This represents a 52.6% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Sight Sciences, Inc.'s operating cash flow?
Sight Sciences, Inc. (SGHT) generated -$22.4M in operating cash flow during fiscal year 2024, representing cash generated from core business activities.
What are Sight Sciences, Inc.'s total assets?
Sight Sciences, Inc. (SGHT) had $142.8M in total assets as of fiscal year 2024, including both current and long-term assets.
What are Sight Sciences, Inc.'s capital expenditures?
Sight Sciences, Inc. (SGHT) invested $385K in capital expenditures during fiscal year 2024, funding long-term assets and infrastructure.
How much does Sight Sciences, Inc. spend on research and development?
Sight Sciences, Inc. (SGHT) invested $18.0M in research and development during fiscal year 2024.
How many shares does Sight Sciences, Inc. have outstanding?
Sight Sciences, Inc. (SGHT) had 51M shares outstanding as of fiscal year 2024.
What is Sight Sciences, Inc.'s current ratio?
Sight Sciences, Inc. (SGHT) had a current ratio of 9.04 as of fiscal year 2024, which is generally considered healthy.
What is Sight Sciences, Inc.'s debt-to-equity ratio?
Sight Sciences, Inc. (SGHT) had a debt-to-equity ratio of 0.45 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Sight Sciences, Inc.'s return on assets (ROA)?
Sight Sciences, Inc. (SGHT) had a return on assets of -36.1% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.
What is Sight Sciences, Inc.'s cash runway?
Based on fiscal year 2024 data, Sight Sciences, Inc. (SGHT) had $120.4M in cash against an annual operating cash burn of $22.4M. This gives an estimated cash runway of approximately 65 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
What is Sight Sciences, Inc.'s Piotroski F-Score?
Sight Sciences, Inc. (SGHT) has a Piotroski F-Score of 3 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Sight Sciences, Inc.'s earnings high quality?
Sight Sciences, Inc. (SGHT) has an earnings quality ratio of 0.43x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Sight Sciences, Inc. cover its interest payments?
Sight Sciences, Inc. (SGHT) has an interest coverage ratio of -10.8x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Sight Sciences, Inc.?
Sight Sciences, Inc. (SGHT) scores 44 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.